Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Maximum Standardized Uptake Volume in Predicting Tumor Spread Through Air Spaces in Stage IA Lung Cancers Smaller than 2 cm.

Cancers·2026
Same author

Extension of Resection in Stage I Thymoma: Less Is Adequate?

The Annals of thoracic surgery·2026
Same author

Mind the Gap Between Radiology and Pathology.

The Annals of thoracic surgery·2026
Same author

Esophageal Exclusion and Retrosternal Bypass in Management of Post-Pneumonectomy Esophagopleural Fistula: A Case Report.

The American journal of case reports·2026
Same author

Subsolid Nodule Management: "To Be Or Not To Be" Lung Cancer….

Chest·2026
Same author

Complications following airway resections: Insights from a large contemporary multi-institutional cohort.

The Journal of thoracic and cardiovascular surgery·2025

Related Experiment Video

Updated: May 25, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Thymoma and thymic carcinoma.

Federico Venuta1, Erino A Rendina, Marco Anile

  • 1Cattedra di Chirurgia Toracica, Policlinico Umberto I, Università di Roma SAPIENZA, V. le del Policlinico 155, 00161, Rome, Italy. federico.venuta@uniroma1.it

General Thoracic and Cardiovascular Surgery
|January 13, 2012
PubMed
Summary
This summary is machine-generated.

Complete surgical resection is crucial for curing thymic tumors. Multimodality approaches, including neoadjuvant and adjuvant therapies, improve outcomes for aggressive thymic neoplasms.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

Related Experiment Videos

Last Updated: May 25, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pathology

Background:

  • Thymic tumors are diverse neoplasms with unpredictable behavior, varying from indolent to metastatic.
  • Thymoma and thymic carcinoma, arising from epithelial cells, are the most common subtypes.
  • Prognostic factors include staging, histology, tumor size, paraneoplastic syndromes, resection completeness, and recurrence.

Purpose of the Study:

  • To review the current understanding of thymic tumors, focusing on prognostic factors and treatment strategies.
  • To emphasize the importance of complete surgical resection as the cornerstone of curative treatment.
  • To discuss the role of multimodality approaches in managing thymic neoplasms.

Main Methods:

  • Review of validated prognostic factors for thymic tumors.
  • Discussion of surgical resection as the gold standard for cure.
  • Analysis of multimodality treatment strategies, including induction and adjuvant therapies.
  • Integration of clinical staging and histology in treatment protocols.
  • Consideration of neoadjuvant therapy for inoperable tumors and adjuvant treatment post-resection.

Main Results:

  • Complete surgical resection is the primary factor for achieving cure in thymic tumors.
  • Multimodality therapy, incorporating induction and adjuvant treatments, is essential for aggressive lesions.
  • Neoadjuvant therapy enhances resectability, survival, and recurrence reduction in inoperable cases.
  • Adjuvant treatment strategies are established for both complete and partial resections.
  • Integrated treatment requires multidisciplinary collaboration.

Conclusions:

  • Complete surgical resection remains the gold standard for thymic tumor cure.
  • Multimodality treatment, guided by staging and histology, is vital for optimal outcomes.
  • Neoadjuvant and adjuvant therapies play significant roles in managing thymic neoplasms.
  • Future treatments may incorporate targeted therapies, necessitating continued research and collaboration.